IDMA appoints Nikkhil K Masurkar as vice chairperson of R&D and Innovation Committee: Our Bureau, Mumbai Friday, May 30, 2025 ...

GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...